# Metformin in Preventing Secondary Gliosis Following Acute Thoraco-Lumbar Spinal Cord Injury

> **NCT07272967** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Badr University** · enrollment: 34 (estimated)

## Conditions studied

- Spinal Cord Injury (SCI)

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07272967
- **Lead sponsor:** Badr University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07272967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07272967, "Metformin in Preventing Secondary Gliosis Following Acute Thoraco-Lumbar Spinal Cord Injury". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07272967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*